MTOR and neoplasm: Remarkably, the phosphatidylinositol 3′-kinase/Akt/mTOR signaling pathway is commonly activated in GBM through constitutive activation of upstream receptor tyrosine kinases, such as EGFR, and/or loss of PTEN tumor suppressor function [91,92].